Blackstone Life Sciences and Ferring Pharmaceuticals to invest $570 mln in new gene therapy firm

Blackstone Life Sciences and Ferring Pharmaceuticals will invest $570 million in FerGene, a new gene therapy company. According to terms of the joint venture, Blackstone will invest $400 million while Ferring will invest up to $170 million.

DealsNorth AmericaUSHealthcareBriefs